熱門資訊> 正文

Kura Oncology在大量首席执行官股票购买数小时后上涨

2026-08-18 05:31

Kura Oncology(KURA) 0
XMax Inc(XMAX) 0

Kura Oncology (KURA) is up ~5% in after-hours trading Monday following the disclosure CEO Troy Wilson bought 100,000 shares through a trust.
One Fish Two Fish Revocable Trust acquired the shares on Monday at an average price of $11.12, giving the purchase a value of ~$1.1M.

More on Kura Oncology

Kura Oncology, Inc. (KURA) Q2 2026 Earnings Call Transcript
Kura Oncology, Inc. (KURA) Discusses Updated FIT 001 Trial Results for Darlifarnib and Cabozantinib in Renal Cell Carcinoma - Slideshow
Kura Oncology, Inc. (KURA) Discusses Updated FIT 001 Trial Results for Darlifarnib and Cabozantinib in Renal Cell Carcinoma Transcript
Kura outlines $90M-$110M 2027 collaboration revenue while targeting 2028 KOMET-017 topline results
Kura Oncology GAAP EPS of -$0.77 beats by $0.12, revenue of $11.8M misses by $8.38M

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。